JP MORGAN/PUT/INTUITIVE SURGICAL/310/0.01/19.07.24 Share Price

Warrant

DE000JB6YKP1

Market Closed - Börse Stuttgart 13:17:29 03/07/2024 BST
0.001 EUR 0.00% Intraday chart for JP MORGAN/PUT/INTUITIVE SURGICAL/310/0.01/19.07.24
3 months-97.67%
6 months-99.55%
Date Price Change
03/07/24 0.001 0.00%
02/07/24 0.001 0.00%
01/07/24 0.001 0.00%
28/06/24 0.001 0.00%
27/06/24 0.001 0.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 01:17 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer J.P. Morgan
WKN JB6YKP
ISINDE000JB6YKP1
Date issued 20/11/2023
Strike 310 $
Maturity 19/07/2024 (16 Days)
Parity 100 : 1
Emission price 0.28
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.001
Delta-0.02x
Omega 14.37
Premium29.09x
Gearing673.85x
Moneyness 0.7106
Difference Strike -124.8 $
Difference Strike %-40.26%
Spread 0.01
Spread %90.91%
Theoretical value 0.006000
Implied Volatility 84.72 %
Total Loss Probability 96.79 %
Intrinsic value 0.000000
Present value 0.006000
Break even 309.35 €
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
434.8 USD
Average target price
428.1 USD
Spread / Average Target
-1.55%
Consensus